40 studies found for:    Temporal arteritis
Show Display Options
Rank Status Study
1 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
2 Terminated Hydroxychloroquine in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: hydroxychloroquine/placebo
3 Active, not recruiting Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis
Interventions: Drug: Abatacept;   Drug: Placebo
4 Recruiting Tocilizumab for Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Tocilizumab + Glucocorticoids (GCs);   Drug: Placebo + Glucocorticoids (GCs)
5 Active, not recruiting Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Prednisone therapy and pharmacokinetic
6 Recruiting Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis;   Arteritis;   Vasculitis;   Aortitis
Intervention:
7 Terminated A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Drug: Infliximab
8 Completed HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: adalimumab;   Drug: placebo
9 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
10 Unknown  Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
11 Recruiting Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Conditions: Horton's Disease;   Infectious Disease;   Neoplasia;   Solid Tumor;   Hemopathy
Interventions: Other: 1 blood sample;   Other: 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
12 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
13 Recruiting Study of the T CD8 Immune Response in Horton's Disease
Condition: Horton's Disease
Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment;   Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment;   Other: Blood sample drawn into a 5 mL dry tube;   Other: 16 blood samples drawn into 6 mL heparinized tubes
14 Recruiting Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)
Condition: Giant Cell Arteritis
Interventions: Procedure: Ultrasound of temporal and axillary arteries;   Procedure: Temporal artery biopsy
15 Recruiting A Study of RoActemra/Actemra (Tocilizumab) in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: prednisone;   Drug: prednisone placebo;   Drug: tocilizumab [RoActemra/Actemra];   Drug: tocilizumab placebo
16 Unknown  Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: methotrexate;   Drug: prednisone
17 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
18 Not yet recruiting Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Horton's Disease: Proof of Concept Study.
Condition: Horton's Disease
Intervention: Drug: corticoids+ tocilizumab 8mg/Kg/month
19 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation
20 Enrolling by invitation VCRC Patient Contact Registry Patient-Reported Data Validation Study
Conditions: Behcet's Disease;   Churg-Strauss Syndrome;   Giant Cell Arteritis;   Wegener Granulomatosis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years